REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Clinical trial NCT07213778 · RECRUITING

Trial details

NCT number: NCT07213778
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Symptomatic Venous Thromboembolism (VTE)

Start date: 2025-11-24
Primary completion: 2027-05-17
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.